As of 2024-12-15, the Relative Valuation of Werewolf Therapeutics Inc (HOWL) is (25.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.65 USD, the upside of Werewolf Therapeutics Inc based on Relative Valuation is -1633.4%.
The range of the Relative Valuation is (26.21) - (26.71) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.8x - 24.1x | 17.3x |
| Forward P/E multiples | 18.8x - 19.2x | 19.0x |
| Fair Price | (26.21) - (26.71) | (25.30) |
| Upside | -1688.3% - -1718.8% | -1633.4% |
| Date | P/E |
| 2024-12-11 | -1.33 |
| 2024-12-10 | -1.33 |
| 2024-12-09 | -1.33 |
| 2024-12-06 | -1.29 |
| 2024-12-05 | -1.27 |
| 2024-12-04 | -1.27 |
| 2024-12-03 | -1.33 |
| 2024-12-02 | -1.41 |
| 2024-11-29 | -1.43 |
| 2024-11-27 | -1.41 |
| 2024-11-26 | -1.41 |
| 2024-11-25 | -1.43 |
| 2024-11-22 | -1.36 |
| 2024-11-21 | -1.28 |
| 2024-11-20 | -1.18 |
| 2024-11-19 | -1.20 |
| 2024-11-18 | -1.23 |
| 2024-11-15 | -1.27 |
| 2024-11-14 | -1.38 |
| 2024-11-13 | -1.47 |
| 2024-11-12 | -1.54 |
| 2024-11-11 | -1.58 |
| 2024-11-08 | -1.65 |
| 2024-11-07 | -1.61 |
| 2024-11-06 | -1.75 |
| 2024-11-05 | -1.62 |
| 2024-11-04 | -1.62 |
| 2024-11-01 | -1.78 |
| 2024-10-31 | -1.83 |
| 2024-10-30 | -1.93 |
| 2024-10-29 | -1.95 |
| 2024-10-28 | -2.12 |
| 2024-10-25 | -2.15 |
| 2024-10-24 | -2.19 |
| 2024-10-23 | -2.44 |
| 2024-10-22 | -2.60 |
| 2024-10-21 | -2.04 |
| 2024-10-18 | -1.47 |
| 2024-10-17 | -1.47 |
| 2024-10-16 | -1.48 |
| 2024-10-15 | -1.44 |
| 2024-10-14 | -1.41 |
| 2024-10-11 | -1.43 |
| 2024-10-10 | -1.30 |
| 2024-10-09 | -1.32 |
| 2024-10-08 | -1.36 |
| 2024-10-07 | -1.41 |
| 2024-10-04 | -1.46 |
| 2024-10-03 | -1.44 |
| 2024-10-02 | -1.45 |